These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 32544232)

  • 21. Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic.
    Cantón R; Gijón D; Ruiz-Garbajosa P
    Curr Opin Crit Care; 2020 Oct; 26(5):433-441. PubMed ID: 32739970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19).
    Khouja T; Mitsantisuk K; Tadrous M; Suda KJ
    J Antimicrob Chemother; 2022 Apr; 77(5):1491-1499. PubMed ID: 35178565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies.
    Chakraborty N; Jha D; Roy I; Kumar P; Gaurav SS; Marimuthu K; Ng OT; Lakshminarayanan R; Verma NK; Gautam HK
    J Nanobiotechnology; 2022 Aug; 20(1):375. PubMed ID: 35953826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of COVID-19: implications for antimicrobial resistance in Africa.
    Iwu CJ; Jordan P; Jaja IF; Iwu CD; Wiysonge CS
    Pan Afr Med J; 2020; 35(Suppl 2):119. PubMed ID: 33282074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the COVID-19 pandemic on the surveillance of antimicrobial resistance.
    Hirabayashi A; Kajihara T; Yahara K; Shibayama K; Sugai M
    J Hosp Infect; 2021 Nov; 117():147-156. PubMed ID: 34562548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial resistance in low- and middle-income countries: current status and future directions.
    Sulis G; Sayood S; Gandra S
    Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides?
    Pérez de la Lastra JM; Anand U; González-Acosta S; López MR; Dey A; Bontempi E; Morales delaNuez A
    Front Immunol; 2022; 13():921483. PubMed ID: 35720330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial Resistance, the COVID-19 Pandemic, and Lessons for the Orthopaedic Community.
    Metsemakers WJ; Zalavras C; Schwarz EM; Chen AF; Trampuz A; Moriarty TF
    J Bone Joint Surg Am; 2021 Jan; 103(1):4-9. PubMed ID: 33259429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics.
    Ukuhor HO
    J Infect Public Health; 2021 Jan; 14(1):53-60. PubMed ID: 33341485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Environmental side effects of the injudicious use of antimicrobials in the era of COVID-19.
    Usman M; Farooq M; Hanna K
    Sci Total Environ; 2020 Nov; 745():141053. PubMed ID: 32702547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collateral damage of the COVID-19 pandemic: Exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes?
    Chibabhai V; Duse AG; Perovic O; Richards GA
    S Afr Med J; 2020 Jun; 110(7):572-573. PubMed ID: 32880323
    [No Abstract]   [Full Text] [Related]  

  • 32. Could the COVID-19 pandemic aggravate antimicrobial resistance?
    Rossato L; Negrão FJ; Simionatto S
    Am J Infect Control; 2020 Sep; 48(9):1129-1130. PubMed ID: 32603851
    [No Abstract]   [Full Text] [Related]  

  • 33. Seizing the moment: now is the time for integrated global surveillance of antimicrobial resistance in wastewater environments.
    Pruden A; Vikesland PJ; Davis BC; de Roda Husman AM
    Curr Opin Microbiol; 2021 Dec; 64():91-99. PubMed ID: 34655936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial Resistance as a Hidden Menace Lurking Behind the COVID-19 Outbreak: The Global Impacts of Too Much Hygiene on AMR.
    Rezasoltani S; Yadegar A; Hatami B; Asadzadeh Aghdaei H; Zali MR
    Front Microbiol; 2020; 11():590683. PubMed ID: 33384670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial resistance and COVID-19: Intersections and implications.
    Knight GM; Glover RE; McQuaid CF; Olaru ID; Gallandat K; Leclerc QJ; Fuller NM; Willcocks SJ; Hasan R; van Kleef E; Chandler CI
    Elife; 2021 Feb; 10():. PubMed ID: 33588991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial resistance and one health in the post COVID-19 era: What should health students learn?
    Elmahi OKO; Uakkas S; Olalekan BY; Damilola IA; Adedeji OJ; Hasan MM; Dos Santos Costa AC; Ahmad S; Essar MY; Thomson DJ
    Antimicrob Resist Infect Control; 2022 Apr; 11(1):58. PubMed ID: 35410463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An insights into emerging trends to control the threats of antimicrobial resistance (AMR): an address to public health risks.
    Asghar A; Khalid A; Baqar Z; Hussain N; Saleem MZ; Sairash ; Rizwan K
    Arch Microbiol; 2024 Jan; 206(2):72. PubMed ID: 38252323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 will further exacerbate global antimicrobial resistance.
    Yam ELY
    J Travel Med; 2020 Sep; 27(6):. PubMed ID: 32539142
    [No Abstract]   [Full Text] [Related]  

  • 39. Antimicrobial resistance vs COVID-19: A bigger challenge in the post-pandemic era!
    Haqqi A; Awan UA; Ahmed H; Afzal MS
    J Formos Med Assoc; 2021 Jul; 120(7):1537-1538. PubMed ID: 33771414
    [No Abstract]   [Full Text] [Related]  

  • 40. How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship?
    Walia K; Mendelson M; Kang G; Venkatasubramanian R; Sinha R; Vijay S; Veeraraghavan B; Basnyat B; Rodrigues C; Bansal N; Ray P; Mathur P; Gopalakrishnan R; Ohri VC
    Lancet Infect Dis; 2023 Aug; 23(8):e301-e309. PubMed ID: 37290476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.